Works matching IS 03065251 AND DT 2019 AND VI 85 AND IP 4


Results: 27
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Post‐marketing dosing changes in the label of biologicals.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 715, doi. 10.1111/bcp.13843
    By:
    • Minnema, Lotte A.;
    • Giezen, Thijs J.;
    • Gardarsdottir, Helga;
    • Egberts, Toine C. G.;
    • Leufkens, Hubert G. M.;
    • Mantel‐Teeuwisse, Aukje K.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    Paediatric extrapolation: A necessary paradigm shift.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 675, doi. 10.1111/bcp.13809
    By:
    • Ollivier, Cécile;
    • Mulugeta, Yeruk (Lily);
    • Ruggieri, Lucia;
    • Saint‐Raymond, Agnes;
    • Yao, Lynne
    Publication type:
    Article
    26

    Issue Information.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 655, doi. 10.1111/bcp.13678
    Publication type:
    Article
    27

    Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 704, doi. 10.1111/bcp.13842
    By:
    • Vlasakakis, Georgios;
    • Napolitano, Antonella;
    • Barnard, Ruth;
    • Brown, Kim;
    • Bullman, Jonathan;
    • Inman, David;
    • Keymeulen, Bart;
    • Lanham, David;
    • Leirens, Quentin;
    • MacDonald, Alexander;
    • Mezzalana, Enrica;
    • Page, Kevin;
    • Patel, Minesh;
    • Savage, Caroline O.;
    • Zamuner, Stefano;
    • Maurik, Andre
    Publication type:
    Article